30.70x
subscribed
Modern Diagnostic & Research Centre
Hospital & Healthcare Services
open
30.70x
subscribed
₹2.72LMin. investment
Modern Diagnostic & Research Centre IPO Details
Issue size
₹37Cr
IPO type
SME
Market Cap
₹135.89CrLower than sector avg
Price range
₹85.00 – ₹90.00
Listing ExchangeBSE
RevenueApr 2024 - Mar 2025
₹77.94CrLower than sector avg
Lot size
1600 shares
Draft Red Herring Prospectus
Read
Growth rate3Y CAGR
17.69%
SectorHospital & Healthcare Services
Price range₹85.00 – ₹90.00
IPO type
SME
Lot size1600 shares
Issue size₹37Cr
Draft Red Herring Prospectus
Read
Market Cap
₹135.89CrLower than sector avg
RevenueApr 2024 - Mar 2025
₹77.94CrLower than sector avg
Growth rate3Y CAGR
17.69%
Checklist
Quality analysis
Revenue growth
Company valuation
Earnings expansion
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial
health at a glance and identify quality investment opportunities easily
Compare
Companies in this sectorObjectives
Capital expenditure
55.80%
Working capital
21.60%
General corporate purposes
19.90%
Repayment of borrowings
2.70%
About Modern Diagnostic & Research Centre
Modern Diagnostic & Research Centre is a service provider in diagnostic and related healthcare tests in India. The company delivers diagnostic services that include core testing, disease diagnosis, prevention, and monitoring for individual patients, hospitals, healthcare providers, and corporate clients. The company offers services through pathology and clinical laboratories, as well as imaging services like ultrasound, colour Doppler, CT scan, MRI scan, digital X-ray, mammography, ECG, PFT, and other specialised diagnostic tests. Currently, it operates 21 centres, which consist of 18 laboratories and three diagnostic centres across 8 states with advanced tech like 3T MRI, 128-slice CT, NGS, and PACS for digital imaging. It also provides additional services, such as online access to test reports, home sample collection, and customised test packages for both individual and institutional clients.
As of June 30, 2025, Pathology made up 80.70% of revenue from operations, while radiology made up 19.30%. Domestic revenue was mainly from Haryana, which contributed 65.80%. India accounted for 96.70% of the revenue, and the remainder came from various countries such as Kenya, Nepal, Ethiopia, Uganda, and Dubai. In FY25, it conducted 3.24 crore tests for 13.69 lakh patients, with B2C revenues forming 48.66% and B2B 51.34%.
Modern Diagnostic & Research Centre Subscription Status
Latest News on Modern Diagnostic & Research Centre

Modern Diagnostic and Research Centre IPO: The ₹36.89 crore initial share sale, with a price band of ₹85 to ₹90 per share, is a fresh issuance of 40,99,200 shares with no offer for sale (OFS) component.
3 min read

Modern Diagnostic and Research Centre IPO: The ₹36.89 crore offer is only a fresh issuance of 40,99,200 shares. Funds raised would be utilised for funding capital expenditure for the purchase of medical equipment for laboratories and diagnostic centres, working capital requirements, debt clearance and general corporate purposes.
3 min read
Frequently asked questions
How to invest in the Modern Diagnostic & Research Centre ?
Investors can apply for the Modern Diagnostic & Research Centre through their Demat account via the stock exchange or through their broker.
What is the issue size of Modern Diagnostic & Research Centre ?
The issue size of the Modern Diagnostic & Research Centre is 37 Cr.
What is 'pre-apply' for Modern Diagnostic & Research Centre ?
Pre-applying for an IPO allows you to submit your application before the official subscription period begins.
Which exchanges will Modern Diagnostic & Research Centre shares list on?
The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.
Bidding closes on 2 Jan 2026, 5:00 PM